Science Foundation of cannabis and unconventional for autism (UF4A) Partner To Advance the successful treatment of autism on cannabis
Posted on 02/02/2012 by admin
Under the new partnership, Dr. Robert Melamed, CEO of the Science of cannabis, will join the board of UF4A as scientific adviser. Melamed UF4A work with to help further document the case studies and monitor the implementation of the property of the Society of cannabinoid treatment of patients with autism next UF4A and medical professionals. [...]
Under the new partnership, Dr. Robert Melamed, CEO of the Science of cannabis, will join the board of UF4A as scientific adviser. Melamed UF4A work with to help further document the case studies and monitor the implementation of the property of the Society of cannabinoid treatment of patients with autism next UF4A and medical professionals. It will also work with legal UF4A progress of the legalization of medical marijuana initiatives.Robert Melamed, Ph.D., Cannabis Science Inc., President & CEO, said: ‘The scientific partnership with cannabis is another step UF4A contributed to achieving our long-term goal of FDA approval of the company products . The good results of autistic patients treated as documented by UF4A are very encouraging and we are excited to take advantage of the record evidence UF4A, gives us the scientific expertise to help develop treatment plans with more refined formulations of cannabis extracts and Sciences to be most scientifically for patients who are accepted. also extremely pleased to work with medical professionals at the University of California at Irvine. It’s a win-win for both organizations innovative medical treatments for cannabis. Our partnership will allow our society and to expose UF4A of studies and anecdotal evidence obtained UF4A occurred catalog of case studies and the science behind the sound treatment plans. This will help the UF4A evidence and Science Partnership of cannabis to get the FDA to formally approve formal testing treatments success for autism UF4A using excerpts from medical cannabinoid formulations and under the supervision of physicians. ‘
‘It’s not a question of need for new treatments, they are doing these treatments for patients,’ he said. ‘If we did, we could avoid many of these cases.’ Prevention of heart disease need
These treatments of autism and the pioneering efforts Jojo mother, Mieko Hester Perez, can be fully review here.
Mieko Hester-Perez and his son ‘Joey’ has inspired many more parents with autistic children to come forward. Studies are under way with children under the supervision of the child and adolescent psychiatrist Dr. Rebecca M. Hedrick, MD
Cannabis Science, Inc. , an American biotechnology pioneer in the development of pharmaceutical products of cannabis, is pleased to announce a partnership with the Foundation for Autism unconventional to exploit the success of Foundation with its proprietary formulas for the treatment of autism for cannabinoids.
All about Priligy .
The partnership will focus on treatments for autism medical marijuana in collaboration with the success of the treatment of cannabis Joey and 10 other families that are now documented by the University of California at Irvine Medical Center Foundation.
This entry was posted in pharmacy. Bookmark the permalink.
Comments are closed.
Recent posts
Lifetime Achievement Award for distinguished academic dedicated to the fight against eating disorders
Deaths related to narcotic painkillers has doubled since 1991: study
Erectile Dysfunction Cure
Science Foundation of cannabis and unconventional for autism (UF4A) Partner To Advance the successful treatment of autism on cannabis
CentraStar Health System Selects ® Mobile for the exchange of health information; Light DME launches Community Health
